Answers are grounded in this paper and cite their sources.
Cross-trait genetic analysis finds correlations between trace element levels and treatment-resistant psychiatric traits, suggesting shared biology without evidence of direct causality.
Trace elements are pivotal to key biological processes, with possible effects on psychopathology. We investigated the hypothesis of shared genetic factors between trace elements levels, treatment resistance and related traits. We used genome‐wide summary statistics for trace elements blood concentration, treatment‐resistant depression (TRD), treatment‐resistant schizophrenia (TRS), and related traits, including anhedonia, neurovegetative symptoms, suicidal ideation, and cognition. Cross‐trait genetic correlations ( r g ) were estimated with High‐Definition Likelihood with Bonferroni correction ( α = 0.0031). Significant r g were tested by two‐sample Mendelian randomization (MR) and polygenic scores (PGSs) in UK Biobank. We found an inverse r g between zinc and TRD ( r g = −0.20, SE = 0.07, p = 4.52 × 10 −3 ), and a consistent non‐significant trend for TRS ( p = 0.06). Copper correlated positively with appetite/weight gain ( r g = 0.11, SE = 0.036, p = 0.0026). MR provided no evidence of causal effects of zinc levels on TRD or copper levels on appetite/weight gain, possibly reflecting weak instruments. The PGS of zinc was not associated with TRD, nor the PGS of copper with appetite/weight gain, in UK Biobank ( n = 15,927 and n = 35,849, respectively). Our results suggested genetic correlations involving zinc and TRD, copper and neurovegetative symptomatology, without support for a causal model or predictive effect of the respective PGSs. This may suggest limited power, residual confounding, or alternative shared genetic architectures.
No takes yet. Share an insight, caveat, or question.
Fabbri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: